Cite

HARVARD Citation

    Wei, B. et al. (2019). Combined plasma and tissue genotyping of EGFR T790M benefits NSCLC patients: a real‐world clinical example. Molecular oncology. 13 (5), pp. 1226-1234. [Online]. 
  
Back to record